A mathematical model of the kinetics of 5-fluorouracil and its metabolites in cancer patients
- 1 January 1991
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 28 (2) , 123-129
- https://doi.org/10.1007/bf00689701
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Clinical Pharmacology of 5-FluorouracilClinical Pharmacokinetics, 1989
- Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.Journal of Clinical Investigation, 1988
- Metabolism of 5-fluorouracil to an N-cholyl-2-fluoro-beta-alanine conjugate: previously unrecognized role for bile acids in drug conjugation.Proceedings of the National Academy of Sciences, 1987
- Nonlinear pharmacokinetic characteristics of 5-fluorouracil (5-FU) in colorectal cancer patientsEuropean Journal of Clinical Pharmacology, 1987
- EVIDENCE FROM RAT HEPATOCYTES OF AN UNRECOGNIZED PATHWAY OF 5-FLUOROURACIL METABOLISM WITH THE FORMATION OF A GLUCURONIDE DERIVATIVE1985
- A mathematical model of the kinetics of 5-fluorouracil and its catabolites in freshly isolated rat hepatocytesBiochemical Pharmacology, 1984
- Nonlinear pharmacokinetics for the elimination of 5-fluorouracil after intravenous administration in cancer patientsCancer Chemotherapy and Pharmacology, 1982
- Rapid catabolism of 5-fluorouracil in freshly isolated rat hepatocytes as analyzed by high performance liquid chromatography.Journal of Biological Chemistry, 1982
- Nonlinear pharmacokinetic models for 5-fluorouracil in man: Intravenous and intraperitoneal routesClinical Pharmacology & Therapeutics, 1980
- An Algorithm for Least-Squares Estimation of Nonlinear ParametersJournal of the Society for Industrial and Applied Mathematics, 1963